Skip to main content
Clinical Trials/IRCT138809092795N1
IRCT138809092795N1CompletedPhase 2

Amiodarone versus propafenone to treat atrial fibrillation after coronary artery bypass graft surgery

Vice chancellor for research,Shiraz University of Medical Sciences0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
no limit to no limit (—)
Sex
All

Inclusion Criteria

  • All candidates for heart surgery ( on pump CABG); who fill out the consent form to participate in research.
  • Exclusion criteria :All patients with a history of sensitivity to propafenone; 'EF <30%; cardiogenic shock; bradycardia; marked hypotension; sick sinus; electrolyte imbalance.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research,Shiraz University of Medical Sciences

Similar Trials

Amiodarone versus propafenone to treat... | Clinical Trial